Date published: 2026-1-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBXO2 Inhibitors

FBXO2 inhibitors belong to a class of chemical compounds that have garnered significant attention in the field of molecular biology and cellular protein regulation research. These inhibitors are specifically designed to target and modulate the activity of FBXO2, which is a member of the F-box protein family. FBXO2 is an essential component of the Skp1-Cullin-F-box protein (SCF) ubiquitin ligase complex, which plays a critical role in the ubiquitin-proteasome pathway, a major cellular mechanism for protein degradation. As an F-box protein, FBXO2 functions as a substrate recognition subunit within the SCF complex, facilitating the ubiquitination and subsequent degradation of specific target proteins by the proteasome. FBXO2 inhibitors exert their effects by interfering with the interaction between FBXO2 and its target proteins or by disrupting FBXO2's ability to recruit substrates for ubiquitination. This interference can have profound implications for protein stability and turnover, influencing various cellular processes, including cell cycle regulation, signal transduction, and response to environmental cues. Researchers employ FBXO2 inhibitors as valuable tools to investigate the specific roles of FBXO2 in different cellular contexts and to better understand the molecular mechanisms underlying protein degradation and turnover. While the specific applications and broader implications of FBXO2 inhibitors are subjects of ongoing research, their utility in elucidating the complexities of protein regulation and degradation pathways is of paramount importance in advancing our understanding of molecular and cell biology.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Binds to the DNA at the transcription initiation complex and prevents elongation by RNA polymerase, potentially decreasing FBXO2 expression.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits eukaryotic protein synthesis by blocking translocation step in mRNA translation, potentially reducing FBXO2 protein levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can broadly affect protein synthesis and gene expression, possibly downregulating FBXO2.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C, leading to altered signaling pathways and possibly decreased expression of FBXO2.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor which may cause feedback inhibition on ubiquitin-proteasome system-related genes, potentially affecting FBXO2 expression.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that could impact the stability of proteins involved in the regulation of gene expression, potentially affecting FBXO2.

Emetine

483-18-1sc-470668
sc-470668A
sc-470668B
sc-470668C
1 mg
10 mg
50 mg
100 mg
$440.00
$900.00
$1400.00
$2502.00
(0)

Inhibits protein synthesis by blocking the ribosomal translocation, potentially leading to decreased levels of FBXO2 protein.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Disrupts microtubule polymerization, affecting cell cycle and potentially altering the expression of various genes including FBXO2.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Binds to heat shock protein 90 (Hsp90) and affects its function, potentially influencing the expression of client proteins like FBXO2.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

A cyclin-dependent kinase inhibitor that may alter the cell cycle and subsequently modulate the expression of various proteins, including FBXO2.